An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers - NASA/ADS

Now on home page

Co-Reads

Volume Content

Graphics

Export Citation

NASA/ADS

An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers

Publication:: PLoS ONE
Pub Date:: December 2017
DOI:: 10.1371/journal.pone.0186459
Bibcode:: 2017PLoSO..1286459A

full text sources

Publisher

|